Seattle's Accelerator Adds PPD as Investor | GenomeWeb

Seattle's Accelerator Adds PPD as Investor

Nov 14, 2008

NEW YORK (GenomeWeb News) – Seattle-based biotechnology investment and management company Accelerator Corporation said today that drug discovery contract research organization PPD has joined as the sixth investor in its Accelerator III investment vehicle.

Accelerator provides resources to biotech companies, including capital financing, facilities, scientific and technical expertise and support, as well as business management and support.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

A Mammoth Competition

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Genetic History, Diversity

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

To Long Life

Researchers link genetic links between education and smoking and longevity.

This Week in PNAS

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.